US2004259132A1PendingUtilityA1
Peptide nucleic acid probes for analysis of pseudomonas (sensu stricto)
Priority: Nov 22, 2002Filed: Apr 8, 2004Published: Dec 23, 2004
Est. expiryNov 22, 2022(expired)· nominal 20-yr term from priority
Inventors:Henrik Stender
C12N 2310/3513C07K 14/21
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a PNA probe that includes a nucleobase sequence suitable for the detection, identification and/or quantitation of Pseudomonas (sensu stricto). In one embodiment, the PNA probe is complementary to a target sequence of 23S rRNA or rDNA from all species of the genus Pseudomonas. The invention has a wide range of important uses including detecting Pseudomonas in a sample of interest.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A PNA probe comprising a nucleobase sequence suitable for the detection, identification and/or quantitation of Pseudomonas (sensu stricto), said PNA probe being complementary to a target sequence of 23S rRNA or rDNA of all species of the genus Pseudomonas, or its complement.
2 . The PNA probe of claim 1 , wherein at least a portion of the probe is at least about 90% identical to the nucleobase sequence or complement thereof selected from the following sequence: CCT ACC ACC TTA MC (Seq. Id. No. 1).
3 . The PNA probe of claim 1 , wherein the probe sequence is 8-17 subunits in length.
4 . The PNA probe of claim 1 for the detection, identification and/or quantification of Pseudomonas (sensu stricto) comprising the following probe sequence: CCT ACC ACC TTA MC (Seq. Id. No. 1), the complement and/or variations thereof.
5 . The PNA probe of claim 1 , wherein the probe is labeled with at least one detectable moiety.
6 . The PNA probe of claim 5 , wherein the detectable moiety or moieties are selected from the group consisting of: a conjugate, a branched detection system, a chromophore, a fluorophore, a spin label, a radioisotope, an enzyme, a hapten, an acridinium ester and a luminescent compound.
7 . The PNA probe of claim 5 , wherein the probe is self-reporting.
8 . The PNA probe of claims 7 , wherein the probe comprises a PNA Linear Beacon.
9 . The PNA probe of claim 1 , wherein the probe is unlabeled.
10 . The PNA probe of claim 1 , wherein the probe is bound to a support.
11 . The PNA probe of claims 1 , wherein the probe further comprises a spacer or a linker.
12 . The PNA probe of claims 1 , wherein in situ hybridization is used for analysis of Pseudomonas (sensu stricto) optionally present in the sample.
13 . A method for the detection, identification and/or quantitation of Pseudomonas (sensu stricto) in a sample, said method comprising: a) contacting at least one of the PNA probes of claim 1 to the sample,
b) hybridizing the PNA probe to a target sequence of species of the genus Pseudomonas in the sample; and
c) detecting the hybridization as being indicative of presence, identity and/or amount of Pseudomonas (sensu stricto) in the sample.
14 . A method according to claim 13 , wherein the analysis takes place in situ.
15 . A method according to claim 12 , wherein the analysis takes place by fluorescence in situ hybridization.
16 . A method according to claims 15 , wherein the analysis does not involve the use of cross-linking reagents or enzymes prior to hybridization.
17 . The method of claim 12 , wherein the method is used to detect a nucleic acid comprising a target sequence wherein said nucleic acid has been synthesized or amplified in a reaction.
18 . The method of claim 17 , wherein preferred nucleic acid synthesis or nucleic acid amplification reactions are selected from the group consisting of: Polymerase Chain Reaction (PCR), Ligase Chain Reaction (LCR), Strand Displacement Amplification (SDA), Transcription-Mediated Amplification (TMA), Rolling Circle Amplification (RCA) and Q beta replicase.
19 . The method of claim 12 , wherein the method further comprises adding at least one blocking probe to reduce or eliminate any hybridization of the PNA probe to non-target sequence.
20 . The method of claim 12 , wherein the target sequence is immobilized to a surface.
21 . The method of claim 12 , wherein said PNA probe is immobilized to a surface.
22 . The method of claim 21 , wherein said PNA probe is one component of an array.
23 . The method of claim 12 , wherein the sample is a biological sample.
24 . The method of claim 23 , wherein the biological sample is blood, urine, secretion, sweat, sputum, stool, mucous, or cultures thereof.
25 . A kit adapted to perform an assay for the detection, identification and/or quantitation of Pseudomonas (sensu stricto) in a sample, wherein said kit comprises: a) a PNA probe according to claim 1 and b) other reagents or compositions necessary to perform the assay.
26 . The kit of claim 25 , wherein Pseudomonas (sensu stricto) and at least one other microorganism optionally present in a sample are independently detected, identified and/or quantitated.
27 . The kit of claim 25 , wherein Pseudomonas (sensu stricto) optionally present in a sample is detected, identified and/or quantitated and its susceptibility to antimicrobial agents is determined.
28 . The kit of claim 25 , wherein the kit is further adapted to perform in an in-situ hybridization assay.
29 . The kit of claim 25 , wherein the kit is further apdapted to perform a real-time PCR assay.
30 . The kit of claim 25 , wherein the kit is adapted to examine clinical samples such as clinical specimens or cultures thereof.
31 . The kit of claim 25 , wherein the kit is adapted to examine food, beverages, water, pharmaceutical products, personal care products, dairy products or environmental samples or cultures thereof.Join the waitlist — get patent alerts
Track US2004259132A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.